MK-2866 and RAD-140 Interaction

Monitor
Researched 90% confidence

MK-2866 and RAD-140 have an interaction requiring monitoring for interaction with 90% confidence. Both are SARMs competing for the same androgen receptor. Stacking MK-2866 with RAD-140 will increase total androgenic load and significantly amplify HPTA suppression beyond what either compound produces alone. If combining, lower doses of each should be used, and bloodwork monitoring of testosterone, LH, and FSH is essential. Most users find RAD-140 alone sufficient and do not benefit meaningfully from adding MK-2866. Both compounds affect the gonads and liver and heart, so monitoring these systems is recommended.

Compound Profiles

MK-2866

Selective Androgen Receptor Modulator | Muscle Wasting Research

MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.

Half-life: ~24 hours Typical dose: 10-25 mg/day oral sarm, anabolic
androgen receptormtormyostatin androgeniccarcinogenic riskhepatotoxichpta suppressive
View full profile

RAD-140

Selective Androgen Receptor Modulator | Investigational SARM

RAD-140 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a full agonist in muscle and bone tissue while exhibiting minimal agonist activity in the prostate and other androgen-sensitive tissues. This tissue selectivity is achieved through differential cofactor recruitment: upon binding to the AR, RAD-140 induces a conformational change that favors interaction with coactivators predominantly expressed in skeletal muscle and bone, rather than those prevalent in prostate or sebaceous glands.

Half-life: ~60 hours Typical dose: 10-20 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskcrosses bbb
View full profile

Combined Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate

Shared Safety Flags

2x 2 androgenic compounds (MK-2866, RAD-140). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (MK-2866, RAD-140). Monitor accordingly.
2x 2 hepatotoxic compounds (MK-2866, RAD-140). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (MK-2866, RAD-140). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (MK-2866, RAD-140). Get lipid panel mid-cycle — consider adding lipid support.

Frequently Asked Questions

Can I take MK-2866 with RAD-140?

Yes, but with caution. Both are SARMs competing for the same androgen receptor. Stacking MK-2866 with RAD-140 will increase total androgenic load and significantly amplify HPTA suppression beyond what either compound produces alone. If combining, lower doses of each should be used, and bloodwork monitoring of testosterone, LH, and FSH is essential. Most users find RAD-140 alone sufficient and do not benefit meaningfully from adding MK-2866. Regular monitoring is advised.

Is MK-2866 and RAD-140 safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: androgenic, carcinogenic risk, hepatotoxic, hpta suppressive, lipid disrupting. Monitor accordingly.

What are the interactions between MK-2866 and RAD-140?

Both are SARMs competing for the same androgen receptor. Stacking MK-2866 with RAD-140 will increase total androgenic load and significantly amplify HPTA suppression beyond what either compound produces alone. If combining, lower doses of each should be used, and bloodwork monitoring of testosterone, LH, and FSH is essential. Most users find RAD-140 alone sufficient and do not benefit meaningfully from adding MK-2866. This assessment has 90% confidence and is based on documented research data.

How should I time MK-2866 and RAD-140?

MK-2866 has a half-life of ~24 hours and RAD-140 has a half-life of ~60 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: MK-2866 vs RAD-140

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.